Skip to main content

March 19, 2019 Newsletter

Health Care & FDA Business Bulletin No. 8 – 2019

Health Care Fraud & Abuse

OIG Approves Limited-Function Smartphones for Patients Under ‘Promotes Access to Care’ Exception to Beneficiary Inducement CMP

Regulatory Updates

New Patient-Brokering Prohibitions Affect Treatment Facilities and Laboratories

State of California Passes Law Limiting Sugary Drinks Offered in Children’s Meals

The New Law Regarding the Regulation of Hemp and CBD

Amendments to Data Breach Notification Law in Colorado Impact HIPAA-Regulated Entities

FDA News

Things to Know Before Marketing a Food, Dietary Supplement or Cosmetics Product on Social Media

FDA Cites Genetech, Inc. and Warns Other Stem Cell Firms Against Marketing Dangerous Unapproved Stem Cell Products

Other

Court Voids New York’s Opioid Surcharge Law

Court of Appeals Upholds Challenge to Executive Order 38 Limiting Executive Compensation